Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.95B | 14.74B | 11.47B | 10.83B | 9.63B | 7.89B | Gross Profit |
13.40B | 12.59B | 11.34B | 10.23B | 9.46B | 7.66B | EBIT |
2.83B | 2.64B | 2.36B | 2.35B | 1.97B | 1.10B | EBITDA |
3.05B | 2.82B | 2.57B | 2.28B | 1.93B | 1.32B | Net Income Common Stockholders |
2.19B | 2.07B | 1.74B | 1.51B | 1.40B | 818.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.72B | 19.26B | 18.60B | 16.06B | 15.52B | 13.04B | Total Assets |
38.18B | 82.99B | 78.36B | 80.95B | 61.89B | 47.48B | Total Debt |
2.45B | 4.03B | 3.48B | 3.79B | 3.17B | 3.28B | Net Debt |
-1.39B | -6.97B | -5.84B | -2.38B | -4.03B | -2.11B | Total Liabilities |
31.74B | 71.33B | 68.17B | 71.52B | 53.59B | 40.31B | Stockholders Equity |
6.37B | 11.67B | 10.21B | 9.46B | 8.24B | 7.11B |
Cash Flow | Free Cash Flow | ||||
1.98B | 1.95B | -3.69B | -19.00M | 6.57B | 3.95B | Operating Cash Flow |
2.17B | 2.15B | -3.51B | 72.00M | 6.65B | 4.07B | Investing Cash Flow |
-2.46B | -968.00M | -274.00M | -7.15B | -5.14B | -4.99B | Financing Cash Flow |
-291.00M | 438.00M | 1.44B | 5.88B | 5.23B | 4.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $31.11B | 26.92 | 40.36% | 0.31% | 26.32% | 8.63% | |
79 Outperform | $12.36B | 30.42 | 19.93% | 1.29% | 24.88% | 39.55% | |
77 Outperform | $29.61B | 14.14 | 18.84% | 1.29% | 11.78% | 25.68% | |
69 Neutral | $9.92B | 18.40 | 11.48% | 1.78% | 12.85% | 20.21% | |
68 Neutral | $4.17B | 14.35 | 16.69% | ― | 67.71% | 19.42% | |
67 Neutral | $10.81B | 18.16 | 6.38% | 2.86% | 16.62% | 139.24% | |
64 Neutral | $12.86B | 9.79 | 7.78% | 16985.65% | 12.28% | -7.82% |
Raymond James Financial announced its annual Analyst & Investor Day scheduled for June 5, 2025, where executive management will present strategic overviews and financial reviews. The event highlights the company’s focus on sustainable growth, market expansion, and leveraging technology to enhance infrastructure, aiming to strengthen its position in the financial services industry.
The most recent analyst rating on (RJF) stock is a Hold with a $158.00 price target. To see the full list of analyst forecasts on Raymond James Financial stock, see the RJF Stock Forecast page.
On May 21, 2025, Raymond James Financial announced the appointment of Mark W. Begor, CEO of Equifax, to its Board of Directors, expanding the board from 12 to 13 members. Begor, who will serve on the Audit and Risk Committees, brings extensive experience in financial services and strategic growth, aligning with Raymond James’ focus on developing an industry-leading technology platform. Additionally, the company declared a quarterly dividend of $0.50 per common share and $0.3984375 per depositary share of its Series B Preferred Stock, payable in July 2025, reflecting its commitment to delivering shareholder value.
The most recent analyst rating on (RJF) stock is a Hold with a $161.00 price target. To see the full list of analyst forecasts on Raymond James Financial stock, see the RJF Stock Forecast page.
On May 21, 2025, Raymond James Financial reported its operating data for April 2025, highlighting a 9% increase in client assets under administration compared to the previous year, while domestic cash sweep and Enhanced Savings Program balances saw a decline due to quarterly fee billings and seasonal tax payments. Despite macroeconomic uncertainties affecting the timing of investment banking closings, the company’s pipeline remains strong, indicating resilience in its operations.
The most recent analyst rating on (RJF) stock is a Buy with a $185.00 price target. To see the full list of analyst forecasts on Raymond James Financial stock, see the RJF Stock Forecast page.
On March 19, 2025, Raymond James Financial reported its operating data for February 2025, highlighting a 12% increase in client assets under administration compared to the previous year, despite a 1% decline from the preceding month due to lower equity markets. The company’s investment banking pipeline remains robust, although macroeconomic uncertainties have led to fewer closings in the first two months of the quarter compared to the previous quarter.